Effects of clopidogrel and ticlopidine on experimental diabetic ischemic retinopathy in rats

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Naunyn-Schmiedeberg's Archives of Pharmacology

• Publication date

  2003-01-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00210-002-0657-4PMID 12595963
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of nitric oxide on the in vitro antiaggregant effect of ticlopidine.

  2002cited by this paper
• Effect of aspirin on prostanoids and nitric oxide production in streptozotocin-diabetic rats with ischemic retinopathy

  2002influential reference
• Nitric Oxide-cGMP and Prostacyclin-cAMP Pathways in Patients with Type II Diabetes and Different Types of Retinopathy

  2002cited by this paper
• Antiplatelet effects of prostacyclin and nitric oxide in patients with type I diabetes and ischemic or edematous retinopathy.

  2001cited by this paper
• New advances in the management of acute coronary syndromes: 1. Matching treatment to risk.

  2001cited by this paper
• Increased prevalence of microthromboses in retinal capillaries of diabetic individuals.

  2001cited by this paper
• Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.

  2001cited by this paper
• Endothelial dysfunction in diabetes

  2000cited by this paper
• Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy

  2000cited by this paper
• Effect of DT-TX 30, a combined thromboxane synthase inhibitor and thromboxane receptor antagonist, on retinal vascularity in experimental diabetes mellitus.

  2000influential reference
• Effect of dipyridamole and aspirin on the platelet-neutrophil interaction via the nitric oxide pathway.

  2000cited by this paper
• Effect of camonagrel, a selective thromboxane synthase inhibitor, on retinal vascularization in experimental diabetes.

  1998influential reference
• Ticlopidine increases nitric oxide generation in heart-transplant recipients: a possible novel property of ticlopidine.

  1998cited by this paper
• Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors.

  1998cited by this paper
• Effect of aspirin plus dipyridamole on the retinal vascular pattern in experimental diabetes mellitus.

  1997cited by this paper
• Blood Vessel Wall Interactions in Diabetes

  1997cited by this paper
• The pyrimido-pyrimidine derivatives, dipyridamole, mopidamol and RA-642, prevent from retinal vascular defects in experimental diabetes mellitus.

  1996cited by this paper
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)

  1996cited by this paper
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

  1996cited by this paper
• Oxidative Stress and Diabetic Vascular Complications

  1996cited by this paper
• Effects of ditazol on the vascular retinal pattern in experimental diabetes in rats.

  1995influential reference
• Platelet abnormalities in diabetes mellitus.

  1993cited by this paper
• Platelet function in diabetes mellitus.

  1992cited by this paper
• Detection of nitric oxide by an electrochemical microprobe

  1992cited by this paper
• Free radicals mediate endothelial cell dysfunction caused by elevated glucose.

  1992cited by this paper
• Platelet Abnormalities in Diabetes Mellitus

  1992cited by this paper
• Effect of antiplatelet drug therapy on the retinal vascular pattern in experimental diabetes mellitus.

  1990cited by this paper
• A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group.

  1989cited by this paper
• Platelet function, platelet prostanoids and vascular prostacyclin in diabetes mellitus.

  1989cited by this paper
• Platelet Aggregation and Coagulation Factors in Insulin Dependent Diabetics With and Without Microangiopathy

  1987cited by this paper
• Tracing Neural Connections with Horseradish Peroxidase

  1984cited by this paper
• Tracing Neural Connections with Horseradish Peroxidase

  1982cited by this paper
• Effect of ticlopidine on arachidonic acid metabolism in platelet phospholipids in vitro.

  1981cited by this paper
• PLATELET FUNCTION IN DIABETES MELLITUS

  1980cited by this paper
• The electronic aggregometer: a novel device for assessing platelet behavior in blood.

  1980cited by this paper
• Effects of ticlopidine on platelet prostaglandin metabolism. Possible consequences for prostacyclin production.

  1979cited by this paper

• Transcriptome sequencing and Mendelian randomization analysis identified biomarkers related to neutrophil extracellular traps in diabetic retinopathy

  2024cites this paper
• Endothelial Glycocalyx in Retina, Hyperglycemia, and Diabetic Retinopathy.

  2023cites this paper
• Highly productive and scalable approach to synthesize ticlopidine: A potent thienopyridine anti-platelet aggregation drug

  2020cites this paper
• Blood flow distribution and the endothelial surface layer in the diabetic retina

  2019cites this paper
• Identification and genetic validation of drug-comorbidity interactions in type 2 diabetes using data-driven disease trajectory analysis

  2019cites this paper
• Genetic Deletion of P2Y2 Receptor Offers Long-Term (5 Months) Protection Against Lithium-Induced Polyuria, Natriuresis, Kaliuresis, and Collecting Duct Remodeling and Cell Proliferation

  2018cites this paper
• Platelet CD40L induces activation of astrocytes and microglia in hypertension.

  2017cites this paper
• Deciphering glycomics and neuroproteomic alterations in experimental traumatic brain injury: Comparative analysis of aspirin and clopidogrel treatment

  2016cites this paper
• Effect of Lycopene on Serum Nitrite-Nitrate Levels in Diabetic Rats

  2015cites this paper
• Monitoring of Diabetic Late Complication

  2015cites this paper
• Measurement of retinal blood flow rate in diabetic rats: disparity between techniques due to redistribution of flow.

  2013cites this paper
• Characterization of the aggregation responses of camel platelets.

  2013cites this paper
• Effects of terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, on retinal vascularity in diabetic rats

  2012cites this paper
• Virgin olive oil administration improves the effect of aspirin on retinal vascular pattern in experimental diabetes mellitus.

  2010cites this paper
• Alteration of nitric oxide-mediated blood flow regulation in diabetes mellitus.

  2010cites this paper
• Effect of pharmaceutical interventions targeting thromboxane receptors and thromboxane synthase in cardiovascular and renal diseases.

  2009cites this paper
• Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension.

  2008cites this paper
• P2 receptors, platelet function and pharmacological implications

  2008cites this paper
• Nitric oxide: Ocular blood flow, glaucoma, and diabetic retinopathy

  2007cites this paper
• Regulation of platelet functions by P2 receptors.

  2006cites this paper
• Effect of Clopidogrel on Nitric Oxide Levels in an Ischemia Reperfusion Model

  2006cites this paper
• Effect of Clopidogrel on Platelet Aggregation and Intimal Hyperplasia following Carotid Endarterectomy in the Rat

  2005cites this paper
• Pharmacological approach to diabetic retinopathy.

  2004cites this paper
• Pathogenesis of Diabetic Retinopathy and Strategy to Develop New Therapeutic Modalities

  2004cites this paper
• In Vitro Effects of Clopidogrel on the Platelet-Subendothelium Interaction, Platelet Thromboxane and Endothelial Prostacyclin Production, and Nitric Oxide Synthesis

  2004cites this paper